New Data Show Early Use of Delve Bio’s Metagenomic Testing Can Reduce Need for Conventional Tests and Overall Length of Stay for Patients with Meningitis/Encephalitis

Delve Bio announces data presented at IDWeek showing mNGS RNA and DNA pathogen detection may lower cost of diagnosing meningitis and encephalitis ...